Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1610 of 5804
-
New pill shows promise for rare bone marrow cancer
Disease control Recruiting nowThis study is a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of nuvisertib (TP-3654) in patients with intermediate or high-risk primary or secondary MF.
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug targets Cancer's fuel supply in rare genetic tumors
Disease control OngoingThis phase II trial studies how well glutaminase inhibitor telaglenastat hydrochloride (CB-839 HCl) works in treating patients with specific genetic mutations and solid tumors or malignant peripheral nerve sheath tumors that have spread to other places in the body (metastatic) or…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Should heart bypass patients get blood thinners for new atrial fibrillation? major trial aims to find out
Disease control Recruiting nowThe primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POA…
Phase: PHASE3 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New implant could help control bladder leaks without daily pills
Disease control OngoingProspective, multi-center, single-arm, seamless phase-pivotal study conducted in participants diagnosed with UUI who have failed or could not tolerate more conservative treatment. The trial will be conducted in two phases. Objective of Phase I: To assess the utilization of the s…
Phase: NA • Sponsor: Neuspera Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could a simple mesh stop painful hernias after surgery?
Prevention Recruiting nowThis trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hernia in subjects at risk for incisional hernia after open midline laparotomy surge…
Phase: NA • Sponsor: C. R. Bard • Aim: Prevention
Last updated Jun 27, 2026 13:07 UTC
-
New PET scan tracer could light up hidden lung cancers
Diagnosis Recruiting nowThe purpose of this study is to look at how safe 89Zr-DFO-SC16.56 is, and how it is processed by the body in people with small cell lung cancer.
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Stem cells could offer new hope for severe eczema sufferers
Disease control OngoingA Multicenter, Randomized, Single-Blind, Phase Ⅱ Clinical Trial and Open Label Long-term Observation Study of ADSTEM Inj. to Evaluate the Safety and Efficacy in Patients with Moderate to Severe Subacute and Chronic Atopic Dermatitis. The aim of this study is to evaluate the safe…
Phase: PHASE2 • Sponsor: EHL Bio Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a simple blood test predict pancreatic cancer before it strikes?
Knowledge-focused OngoingThis study is designed to develop a cohort of individuals without pancreatic cancer, but who are at increased risk of developing it due to family history or genetic predisposition. These high-risk individuals will be asked to provide baseline and annual (serial) follow-up blood s…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Nerve surgery offers new hope for silent breathing struggle
Disease control Recruiting nowThis is a prospective observational study examining the treatment outcomes of selective laryngeal reinnervation procedures for patients with bilateral vocal fold paralysis.
Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for tough anemia: drug boosts blood cells in failed cases
Disease control CompletedThis was a non-randomized, open-label, phase II study to assess the efficacy and safety of eltrombopag in Chinese subjects with refractory or relapsed severe aplastic anemia (SAA). Treatment with eltrombopag was started at 25 mg/day and increased by 25 mg/day every 2 weeks accord…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Walking analysis may save diabetic feet from ulcers and amputation
Disease control Recruiting nowDetermining whether the utilization of Noraxon myoRESEARCH Software gait analysis Evaluation and orthotic gait Correction can reduce diabetic foot ulceration Or subsequent amputation in patients with a history of a diabetic foot ulceration.
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug combo targets brain tumors with genetic flaw
Disease control OngoingThis study will test the safety of the study drug, GDC-0084, in combination with radiation therapy in people who have solid tumor brain metastases or leptomeningeal metastases. All participants will have cancer with a PIK3CA mutation. The researchers will test increasing doses of…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Scientists build atlas of Pre-Cancerous lung lesions to stop cancer before it starts
Knowledge-focused OngoingThis protocol pertains specifically to the prospective lung squamous cell carcinoma pre-malignant lesion (PML) cohort that will form a primary study group for the Lung Pre-Cancer Atlas.
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Mass screening in bhutan aims to stop stomach cancer before it starts
Knowledge-focused CompletedBackground: Helicobacter pylori is a major risk factor for gastric cancer, yet in many developing countries, including Bhutan where gastric cancer incidence is high, access to screening and eradication is limited. The investigators conducted the first large-scale, population-base…
Phase: NA • Sponsor: Zero Helicobacter IGAN Network • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New gout drug shows promise in lowering uric acid levels
Disease control CompletedThe aim of this 12-week randomized multicenter double-blind parallel group placebo-controlled dose finding study is to assess the efficacy and safety of three different doses of LC350189 in subjects with hyperuricemia and a diagnosis of gout.
Phase: PHASE2 • Sponsor: LG Chem • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Old drug, new hope: cabergoline trial targets endometriosis pain
Symptom relief CompletedEndometriosis is dependent on angiogenesis (the sprouting of new blood vessels) for its growth and maintenance, but the side effects of currently approved angiogenesis inhibitors make these agents inappropriate for use in reproductive-age patients. This obstacle will be overcome …
Phase: PHASE2 • Sponsor: Boston Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Blood test could spare kidney patients painful biopsies
Diagnosis Recruiting nowDemonstrate the relationship between DD-cfDNA levels and HLA antibodies in blood, and the Molecular Microscope® (MMDx) Diagnostic System results in indication biopsies.
Sponsor: University of Alberta • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Can a common sedative shield your brain after bypass surgery?
Disease control Recruiting nowAnesthesia is a drug induced, reversible, comatose state that facilitates surgery and it is widely assumed that cognition returns to baseline after anesthetics have been eliminated. However, many patients have persistent memory impairment for weeks to months after surgery. Cardia…
Phase: PHASE4 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Ovarian cancer drug niraparib tested in 850 korean women
Disease control Completed1. To evaluate the efficacy and safety of niraparib in Korean women with primary and recurrent epithelial ovarian cancer who underwent niraparib maintenance therapy 2. To evaluate the efficacy and safety of salvage niraparib therapy in Korean women with heavily pretreated epithel…
Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could less radiation be better for nasopharyngeal cancer patients?
Disease control OngoingTo evaluate the long-term locoregional control, survival rate, late toxicity and quality of life after reducing the target volume in patients with locoregionally advanced nasopharyngeal carcinoma patients treated with induction chemotherapy plus concurrent chemoradiotherapy.
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 26, 2026 13:24 UTC